Maestroni et al., Immunology, 63(3), 465-470 (abstract), 1988. |
Chemical & Engineering News, p. 40, "The Biochemically Active Pineal Gland May Be As Important As Any Other", May 1, 1967. |
J. Barchas, et al., Nature, vol. 214, pp. 919-920, "Acute Pharmacology of Melatonin", May 27, 1967. |
A. Miles, et al., CRC Critical Reviews in Clinical Laboratory Sciences, vol. 25, Issue 3, pp. 231-253, "Melatonin: Perspectives In Laboratory Medicine and Clinical Research", 1987. |
R. Reiter, et al., Life Sciences, vol. 60, No. 25, pp. 2255-2271, "Pharmacological Actions Of Melatonin In Oxygen Radical Pathophysiology", 1997. |
J.M. Guerrero, et al., J. Pineal Res., vol. 23, pp. 24-31, Melatonin Prevents Increases In Neural Nitric Oxide and Cyclic GMP Production After Transient Brain Ischemia And Reperfusion In The Mongolian Gerbil (Meriones Unguiculatus), 1997. |
S. Cho, et al., Brain Research, vol. 755, pp. 335-338, "Melatonin Administration Protects CA1 Hippocampal Neurons After Transient Forebrain Ischemia In Rats", 1997. |
M.D. Ginsberg, et al., Stroke, vol. 20, No. 12, pp. 1627-1642, "Rodent Models Of Cerebral Ischemia", Dec., 1989. |
H. Manev, et al., The FASEB Journal., vol. 10, pp. 1546-1551, "Increased Brain Damage After Stroke Or Excitotoxic Seizures In Melatonin-Deficient Rats", Nov., 1996. |
R.J. Reiter, Acta Neurobiologi.ae butted. Experimentalis, vol. 54 (Suppl.), pp. 31-39, "Pineal Function During Aging: Attenuation Of The Melatonin Rhythm and Its Neurobiological Consequences", 1994. |
R.J. Reiter, The FASEB Journal., vol. 9, No. 7, pp. 526-533, "Oxidative Processes And Antioxidative Defense Mechanisms In The Aging Brain", May, 1995. |
E.A. Lane, et al., The Journal of Clinical Endocrinology and Metabolism, vol. 61, No. 6, pp. 1214-1216, "Pharmacokinetics Of Melatonin In Man: First Pass Hepatic Metabolism", Dec., 1985. |
O. Vakkuri, et al., Life Sciences, vol. 37, pp. 489-495, "Oral Administration And Distribution Of Melatonin In Human Serum, Saliva And Urine", 1985. |
M. Aldhous, et al., British Journal of Clinical Pharmacology, vol. 19, No. 4, pp. 517-521, "Plasma Concentrations Of Melatonin In Man Following Oral Absorption Of Different Preparations", Apr., 1985. |
F. Waldhauser, et al., Neuroendocrinology, vol. 39, No. 4, pp. 307-313, "Bioavailability Of Oral Melatonin In Humans", Oct., 1984. |
P.A. Vitte, et al., Journal of Pineal Research, vol. 5, No. 5, pp. 437-453, "Plasma, Cerebrospinal Fluid, And Brain Distribution Of .sup.14 C-Melatonin In Rat: A Biochemical And Autoradiographic Study", 1988. |
D. Le Bars, et al., International Journal of Radiation Applications and Instrumentation Part B, vol. 18, No. 3, pp. 357-362, "Pet And Plasma Pharmacokinetic Studies After Bolus Intravenous Administration Of [.sup.11 C]Melatonin In Humans", 1991. |
W.A. Pulsinelli, et al., Stroke, vol. 10, pp. 267-272, "A New Model Of Bilateral Hemispheric Ischemia In The Unanesthetized Rat", 1979. |